NEXTBio Capital invests in breakthrough medicine through application of next-generation technologies.

NEXTBio Capital

5AM Ventures is a leading venture capital firm that specializes in building next-generation life science companies. The firm focuses on early-stage investing in the biopharmaceutical, medical technology, and health care sectors.

John Diekman

Andrew Schwab

5AM Ventures

ARCH Venture Partners is an American venture capital firm that primarily invests in companies in the biotechnology industry, as well as in other industries such as semiconductors and technology. The firm was initially created by the University of Chicago and the Argonne National Laboratory to commercialize their technology, and it has since become an independent firm with a focus on investing in transformative and bold ideas.

Clinton Bybee

Robert Nelsen

Steven Gillis

Keith Crandell

Steven Lazarus

ARCH Venture Partners

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas in the technology and healthcare sectors. With a portfolio of 70 IPOs and 145 M&As, Canaan is dedicated to building the future of healthcare and technology through agile and imaginative companies.

Metric
Company Name	NEXTBio Capital	5	ARCH Venture Partners	Canaan
Symbol
MSH ID	COM:NEXTBIOCAPITAL	COM:5AMVENTURES	COM:ARCHVENTURE	COM:CANAAN
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services	Financial Services	Technology
Industry	Biotechnology	Venture Capital	Venture Capital	Venture Capital
Country	US	US	US
Stage
Employee Count		45	60	11
Website	nextbiocapital.com	5amventures.com	archventure.com	canaan.com
LinkedIn		5amventures	avpvc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	16.72K	8.60K
Web Traffic Growth	1.33	0.01
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NEXT

COM:NEXTBIOCAPITAL

NEXTBio Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue